Pharmacy benefit managers (PBMs) have become the hot potato of the healthcare industry that nobody wants to hold. State and...
The financial impact of chronic disease in the U.S. is sobering. According to the Centers for Disease Control (CDC), 90%...
They’re often called the four “pillars” of cancer treatment because of their prevalence. Physicians have used surgery, chemotherapy, radiation therapy,...
Now that the Centers for Medicare & Medicaid Services (CMS) has lowered the boom on payers by dropping the star...
Economists can’t agree if the U.S. is headed for a “soft landing” recession, a hard landing, or no recession at...
While spending on oncology drugs in the U.S. is anticipated to reach $125 billion by 2027, overall drug savings of...
After attending my first AHIP (America’s Health Insurance Plans) national conference, I was struck by the level of engagement and...
According to the American Cancer Society, more than 18 million people in the U.S. have cancer, and many of them...
With the median cost of new oncology drugs over $260,000, it’s no wonder payers continue to look for opportunities to...
Aside from non-melanoma skin cancer, prostate cancer is the most common cancer among men in the United States. For example,...
Introduction Artificial intelligence (AI) is transforming the healthcare industry in unprecedented ways, including how healthcare payers manage and deliver care...
Nurses perform the most essential tasks in healthcare and often serve as the first point of contact for most patients....